Speaker illustration

Ms Sofia Nilsson

Ribocure Pharmaceuticals, Gothenburg (Sweden)

Member of:

European Society of Cardiology

FXI levels are related to endothelial function and endothelial activation biomarkers in patients with recent acute coronary syndrome

Event: ESC Congress 2025

Topic: Thrombosis, Platelets, and Coagulation

Session: Insights into pathophysiology of acute coronary syndromes

Thumbnail

High apo-CIII level correlates with poor lipid status, pro-inflammatory and fibrotic biomarker profile, and adverse cardiovascular outcome in patients with recent acute coronary syndrome

Event: ESC Congress 2025

Topic: Biomarkers

Session: Pathophysiology in acute coronary syndromes (1)

Thumbnail